Latest News "Stem Cell Therapeutics completes Trillium merger" go »
For information on Stem Cell Therapeutics click here
Trillium Therapeutics Inc. (TTI) is a research and development
biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.
